RareMed Solutions is proud to congratulate our Director of Specialty Markets, Gannon Vanscoy, on his recognition as a 2019 Pittsburgh Business Times 30 Under 30 honoree. Each year, The Pittsburgh Business Times identifies 30 individuals under the age of 30 years, who have accomplished exceptional career milestones and made great contributions to our Pittsburgh community. The 2019 honorees represent a wide range of industries, including game design, public works, real estate, and rare pharmacy services.
“It is a great honor and humbling to be recognized by the Pittsburgh Business Times as an influential person under 30” said Gannon Vanscoy. “It is not only exciting for me, but for RareMed as well. We’ve worked hard to build something special that caters to rare disease patients and biopharmaceutical companies like no pharmacy (hub) services provider 
has before. We set out to change the industry, to positively affect patient care, and to create a purpose-driven Pittsburgh company. This is my opportunity to contribute to improving the lives of people who need it.”
Numerous previous recipients of the 30 Under 30 award continue to influence Pittsburgh’s businesses and currently serve as many of our CEOs, community leaders, and local entrepreneurs who inspire Pittsburgh’s industrious passions.
The 2019 30 Under 30 award program will be held at a celebratory reception on August 15th at the Ace Hotel Pittsburgh. Click here to read Gannon’s 30 Under 30 profile published by the Pittsburgh Business Times.
About Gannon Vanscoy
Gannon Vanscoy is a cofounder of RareMed Solutions, the nation’s first rare disease-focused pharmacy services provider. As such, Gannon is a pioneer, launching a company that provides care to people who suffer from rare and devastating diseases. Over the past 12 months Gannon has guided the company to success, where RareMed has won and implemented a growing number of major biopharma service program contracts. In his role as the Director of Specialty Markets, Gannon leads RareMed’s multimillion dollar business development, financial analysis, and strategy initiatives. His leadership and dedication to the firm drive RareMed’s rapid growth and have led to the creation of a new standard of quality in a formerly commoditized and underserved pharmacy services market.
Gannon leverages his background in finance at RareMed, tapping into his five years of Wall Street experience in corporate banking at Barclays and Citigroup in New York City. This work history gives him a unique financial background that he leverages to RareMed’s advantage. Gannon is responsible for forecasting financial projections, leading capital discussions, and managing the firm’s pricing models. Gannon’s work ensures that RareMed’s growth is both sustainable and profitable.
After banking, Gannon returned to Pittsburgh and began cultivating his entrepreneurial expertise in rare and orphan disease states at PANTHERx Rare Pharmacy, where he participated in a rotational development program. He graduated cum laude with a degree in finance from the University of Miami’s School of Business Administration. He is also currently enrolled in an executive graduate program at the University of Pittsburgh for a Master of Pharmacy Business Administration degree.
About RareMed Solutions
RareMed Solutions is a national pharmacy patient services provider purely focused on orphan and precision medicines. Founded on the philosophy that nothing is more important than providing the highest quality of care to patients, RareMed is frequently the first point of contact for healthcare providers and patients seeking treatment for rare diseases. RareMed provides healthcare professional education, patient adherence programs, nursing support, copay support, and financial assistance programs for biopharma manufacturers so their populations of rare disease patients can be better served. RareMed has a uniquely-purposed pharmacy which is on track to serve all 50 states in the coming months. This will allow RareMed to provide manufacturer-sponsored free rare drug programs nationwide for patients who cannot otherwise afford their treatment.
RareMed focuses solely on small rare disease populations and provides white glove service for patients who need it the most. The firm also utilizes a proprietary software which enables the creation of highly customized solutions for our biopharma clients.